417 related articles for article (PubMed ID: 20585095)
41. Interferon alfa and zidovudine in adult T-cell leukemia-lymphoma.
Pagano JS
N Engl J Med; 1995 Nov; 333(19):1285-6. PubMed ID: 7566010
[No Abstract] [Full Text] [Related]
42. Interferon alfa and zidovudine in adult T-cell leukemia-lymphoma. Lymphoma Study Group of the Japan Clinical Oncology Group.
Tobinai K; Kobayashi Y; Shimoyama M
N Engl J Med; 1995 Nov; 333(19):1285; author reply 1286. PubMed ID: 7566009
[No Abstract] [Full Text] [Related]
43. Arsenic trioxide (As
Marçais A; Cook L; Witkover A; Asnafi V; Avettand-Fenoel V; Delarue R; Cheminant M; Sibon D; Frenzel L; de Thé H; Bangham CRM; Bazarbachi A; Hermine O; Suarez F
Retrovirology; 2020 Mar; 17(1):5. PubMed ID: 32199462
[TBL] [Abstract][Full Text] [Related]
44. [Progress in the management of ATL].
Ishitsuka K
Rinsho Ketsueki; 2017; 58(6):676-682. PubMed ID: 28680001
[TBL] [Abstract][Full Text] [Related]
45. The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.
Kchour G; Rezaee R; Farid R; Ghantous A; Rafatpanah H; Tarhini M; Kooshyar MM; El Hajj H; Berry F; Mortada M; Nasser R; Shirdel A; Dassouki Z; Ezzedine M; Rahimi H; Ghavamzadeh A; de Thé H; Hermine O; Mahmoudi M; Bazarbachi A
Retrovirology; 2013 Aug; 10():91. PubMed ID: 23962110
[TBL] [Abstract][Full Text] [Related]
46. Treatment of adult T-cell leukaemia/lymphoma: is the virus a target?
Cook LB; Taylor GP
Curr Opin Infect Dis; 2015 Dec; 28(6):583-8. PubMed ID: 26381999
[TBL] [Abstract][Full Text] [Related]
47. Hemophagocytic syndrome as a presenting sign of transformation of smoldering to acute adult T-cell leukemia/lymphoma: efficacy of anti-retroviral and interferon therapy.
Aouba A; Lambotte O; Vasiliu V; Divine M; Valensi F; Varet B; Bazarbachi A; Hermine O
Am J Hematol; 2004 Jun; 76(2):187-9. PubMed ID: 15164389
[TBL] [Abstract][Full Text] [Related]
48. Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.
Mone A; Puhalla S; Whitman S; Baiocchi RA; Cruz J; Vukosavljevic T; Banks A; Eisenbeis CF; Byrd JC; Caligiuri MA; Porcu P
Blood; 2005 Nov; 106(10):3380-2. PubMed ID: 16076875
[TBL] [Abstract][Full Text] [Related]
49. Current management of adult T-cell leukemia/lymphoma.
Tobinai K
Oncology (Williston Park); 2009 Dec; 23(14):1250-6. PubMed ID: 20120837
[TBL] [Abstract][Full Text] [Related]
50. Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.
Kchour G; Makhoul NJ; Mahmoudi M; Kooshyar MM; Shirdel A; Rastin M; Rafatpanah H; Tarhini M; Zalloua PA; Hermine O; Farid R; Bazarbachi A
Leuk Lymphoma; 2007 Feb; 48(2):330-6. PubMed ID: 17325893
[TBL] [Abstract][Full Text] [Related]
51. Adult T-cell leukemia/lymphoma in the Middle East: first report of two cases from Lebanon.
Bitar N; Hajj HE; Houmani Z; Sabbah A; Otrock ZK; Mahfouz R; Zaatari G; Bazarbachi A
Transfusion; 2009 Sep; 49(9):1859-64. PubMed ID: 19453978
[TBL] [Abstract][Full Text] [Related]
52. Long-term study of indolent adult T-cell leukemia-lymphoma.
Takasaki Y; Iwanaga M; Imaizumi Y; Tawara M; Joh T; Kohno T; Yamada Y; Kamihira S; Ikeda S; Miyazaki Y; Tomonaga M; Tsukasaki K
Blood; 2010 Jun; 115(22):4337-43. PubMed ID: 20348391
[TBL] [Abstract][Full Text] [Related]
53. Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma.
Katsuya H; Ishitsuka K
J Clin Exp Hematop; 2017 Dec; 57(3):87-97. PubMed ID: 28592744
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis and management of adult T-cell leukemia/lymphoma.
Ishitsuka K
Semin Hematol; 2021 Apr; 58(2):114-122. PubMed ID: 33906721
[TBL] [Abstract][Full Text] [Related]
55. Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?
Nasr R; El Hajj H; Kfoury Y; de Thé H; Hermine O; Bazarbachi A
Viruses; 2011 Jun; 3(6):750-69. PubMed ID: 21994752
[TBL] [Abstract][Full Text] [Related]
56. Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma: case reports of Japanese patients.
Ishitsuka K; Katsuya H; Toyota T; Ishizu M; Kunami N; Fujita M; Sasaki H; Takamatsu Y; Uchiyama M; Fujikane H; Ogata K; Hara S; Tamura K
Int J Hematol; 2010 Dec; 92(5):762-4. PubMed ID: 21080125
[TBL] [Abstract][Full Text] [Related]
57. Adult T-Cell Leukemia/Lymphoma.
Mehta-Shah N; Ratner L; Horwitz SM
J Oncol Pract; 2017 Aug; 13(8):487-492. PubMed ID: 28796966
[TBL] [Abstract][Full Text] [Related]
58. Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients.
Matutes E; Taylor GP; Cavenagh J; Pagliuca A; Bareford D; Domingo A; Hamblin M; Kelsey S; Mir N; Reilly JT
Br J Haematol; 2001 Jun; 113(3):779-84. PubMed ID: 11380470
[TBL] [Abstract][Full Text] [Related]
59. Unsuccessful association of zidovudine and interferon alpha for acute adult T-cell leukemia lymphoma.
Dega H; Chosidow O; Charlotte F; Francès C; Herson S; Leblond V
Dermatology; 1999; 198(1):103-5. PubMed ID: 10026418
[No Abstract] [Full Text] [Related]
60. Adult T-cell Leukemia/Lymphoma: A Problem Abroad and at Home.
Dittus C; Sloan JM
Hematol Oncol Clin North Am; 2017 Apr; 31(2):255-272. PubMed ID: 28340877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
